Skip to main content

Table 5 Comparison between patients undergoing surgery at < 14 and > 14 days following PTGBD

From: The influence of the interval between percutaneous transhepatic gallbladder drainage and cholecystectomy on perioperative outcomes: a retrospective study

Factors ≤ 14-day group (n = 10) ≥ 15-day group (n = 12) P P
Gender (Male), n (%) 9 (64.3) 5 (62.5) 0.9333
Age (years) 75.4 ± 2.7 77.5 ± 3.5 0.6324
Comorbidity (Yes), n (%) 10 (71.4) 8 (100.0) 0.0426
Anticoagulant medication (Yes), n (%) 2 (14.3) 0 (0.0) 0.1658
ASA status 2.36 ± 0.18 2.38 ± 0.24 0.9529
Cholecystitis grade 1.9 ± 0.2 1.5 ± 0.2 0.2092
WBC before PTBGD (/mL) 13,141 ± 1800 14,402 ± 2382 0.6771
CRP before PTGBD (mg/dL) 18.19 ± 2.85 14.80 ± 3.77 0.4807
WBC before surgery (/mL) 10,191 ± 1492 7198 ± 1973 0.2404
CRP before surgery (mg/dL) 11.13 ± 2.00 0.99 ± 2.64 0.0007
Surgical complications (Yes), n (%) 1 (7.1) 1 (12.5) 0.6795
Operating time (min) 117.4 ± 10.6 128.5 ± 14.1 0.5345
Blood loss (g) 176.1 ± 63.8 116.1 ± 84.4 0.5772
Adhesion grade 1.6 ± 0.2 1.9 ± 0.3 0.5082
Laparotomy conversion (Yes), n (%) 5 (35.7) 2 (25.0) 0.5999
Hospitalization after surgery (days) 12.8 ± 4.9 25.9 ± 6.5 0.1259
Total hospitalization (days) 19.5 ± 7.2 59.9 ± 9.5 0.0060
  1. Bold values indicate significant differences
  2. Data are presented as mean ± standard deviation unless otherwise indicated
  3. ≤ 14-day group: patients with an interval between PTGBD and surgery ≤ 14 days, ≥ 15-day group: patients with an interval between PTGBD and surgery ≥ 15 days, PTGBD: percutaneous transhepatic gallbladder drainage, WBC: white blood cell, CRP: C-reactive protein, ASA: American Society of Anesthesiologists